RAPT Therapeutics Inc

RAPTStocksPharmaceuticals MajorUnited StatesNasdaqUSD

Price

$58.00

Today

-0.0%

YTD

+71.8%

About

Rapt Therapeutics Inc is a global biopharmaceutical company focused on discovering and commercialising immune-mediated therapies. It designs and develops therapeutics that aim to tackle unmet medical needs, primarily in cancer and inflammatory diseases. Based in the biotechnology industry, Rapt Therapeutics Inc uses technology to develop highly selective small molecules that target elusive diseases by modulating critical immune responses. The company has developed a pipeline of drug candidates targeting inflammatory and oncological diseases such as asthma and gastric cancer. Track the share price of RAPT by adding it to your eToro watchlist.

Price chart

Closing price history for RAPT (1D candles).

Open positions

Current open positions for this instrument from your live portfolio.

Open positions

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-5.24

P/S (TTM)0.00

P/B (TTM)6.43

Market cap$1.61B

Cap tierSmall-cap

Industry avg P/E-7.28

Profitability

Gross marginUnknown

EBIT margin0.00%

Net marginUnknown

ROE-85.37%

ROA-77.05%

Earnings & Revenue

Revenue (TTM)$0.00

Revenue growth (1Y)-100.0%

EPS (TTM)-$11.07

Free cash flow$-86.66M

Total debt$2.60M

Dividends & Risk

Dividend rate$0.00

Dividend yield0.00%

Beta (5Y)1.58

Employees68

Next earnings5 Mar '26

Trade history

Closed trades

Realized return

+0.0%

No stored closed trades exist for this instrument yet.